Furthermore, it was interesting to note that the population of CD4+ TNFR2+ PD-1+ TILs was reduced by chemotherapy (Figure 4(C1)), and tended to correlate with the high tumor volumes that characterized the vehicle-treated tumor-bearing mice (Figure 4(C2)). The gene discussed is CD4; the disease is neoplasm.